EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Multi-Target Phytotherapeutic Approach to Benign Prostatic Hyperplasia: Preclinical Characterization of a PhytoBPH-Mix

Chiara Amante iD, Chiara De Soricellis iD, Maria Rosaria Sellitto, Giovanni Falcone iD, Luigi Luccheo, Gianni Luccheo iD, Pasquale Del Gaudio iD

Nutrients · 2026

DOI: 10.3390/nu18040650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Chiara Amante und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Plant Extracts, Phytotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign prostatic hyperplasia (BPH) is a prevalent condition affecting over 50% of men aged 60 and above, often leading to lower urinary tract symptoms that significantly impact quality of life. Current pharmacological treatments, including α-adrenergic receptor antagonists and 5α-reductase inhibitors, are associated with adverse effects, prompting the exploration of alternative therapies. This study investigates the potential role of a novel multi-component phytocomplex (PhytoBPH-Mix) comprising Serenoa repens, Pygeum africanum, Urtica dioica, Epilobium angustifolium L., Protium heptaphyllum, lycopene, Vitamin E, zinc, and selenium.

Methods

The anti-androgenic, anti-inflammatory, and antimicrobial properties of the mixture were evaluated in vitro.

Results

The formulation significantly inhibited 5α-reductase activity, reduced the release of pro-inflammatory cytokines (IL-6 and TNF-α), and exhibited antibacterial effects against E. coli compared to individual extracts.

Conclusions

These findings suggest that this specific mixture offers a promising natural alternative or an adjuvant for managing BPH by targeting multiple pathological mechanisms with minimal side effects and could also serve as an effective adjuvant in conventional therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaPlant ExtractsPhytotherapyMaleSerenoaHumansAnti-Inflammatory AgentsEpilobiumUrtica dioica5-alpha Reductase InhibitorsEscherichia coliLycopeneAnimalsVitamin ETumor Necrosis Factor-alphaAnti-Bacterial Agents

Stichwörter der Autor:innen

Pygeum africanumSerenoa repensbenign prostatic hyperplasialower urinary tract symptoms (LUTS)phytotherapeutic

Substanzen

Plant ExtractsAnti-Inflammatory Agents5-alpha Reductase InhibitorsLycopeneVitamin ETumor Necrosis Factor-alphaAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.
  • Anvest Health s.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, SA, Italy.

ORCID-Profile: Chiara Amante, Chiara De Soricellis, Giovanni Falcone, Gianni Luccheo, Pasquale Del Gaudio

Zitieren

APA

Amante, C., De Soricellis, C., Sellitto, M. R., Falcone, G., Luccheo, L., Luccheo, G., & Gaudio, P. D. (2026). A Multi-Target Phytotherapeutic Approach to Benign Prostatic Hyperplasia: Preclinical Characterization of a PhytoBPH-Mix. Nutrients. https://doi.org/10.3390/nu18040650

Vancouver

Amante C, De Soricellis C, Sellitto MR, Falcone G, Luccheo L, Luccheo G, et al. A Multi-Target Phytotherapeutic Approach to Benign Prostatic Hyperplasia: Preclinical Characterization of a PhytoBPH-Mix. Nutrients. 2026. doi:10.3390/nu18040650

BibTeX
@article{Amante2026,
  author = {Amante, Chiara and De Soricellis, Chiara and Sellitto, Maria Rosaria and Falcone, Giovanni and Luccheo, Luigi and Luccheo, Gianni and Gaudio, Pasquale Del},
  title = {A Multi-Target Phytotherapeutic Approach to Benign Prostatic Hyperplasia: Preclinical Characterization of a PhytoBPH-Mix},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18040650}
}
Kostenlos starten →